Over the last 150 years, our life expectancy has grown, from 40 years in 1850 to over 90 years today in some countries. This can be attributed to advances in medical science, improvements in public health, and equitable access to healthcare, especially for maternal and infant care.

What does the future hold for longevity and ageing?

According to the World Health Organisation, almost 70 percent of the population can expect to live longer than 85 years by 2050. Furthermore, by that time between 30% to 55% of the world's elderly will suffer from frailty. And if the right rejuvenation therapies are not used proactively in young and middle-aged people today, many of them will end up in their final years needing expensive medical care due to chronic diseases and disability.

Reaching the goal of enhanced longevity requires a paradigm shift in science, both in terms of the conceptualization of ageing and how research funding and knowledge are directed. It also requires a shift in our perceptions about aging. Currently, society considers older people to be less productive and burdensome to society. This view needs to change. We need to increase support for biotech efforts geared towards developing rejuvenation therapies that can be given to human beings starting at midlife.

The big question is whether we will be overwhelmed by a ‘silver tsunami’ of elderly people with poor health, or whether we will use the latest research findings to rejuvenate the elderly and extend their lifespans?

Our Longevity Futures is a show where I, Chris Curwen, speak to scientists, engineers, entrepreneurs, doctors, politicians, and community activists who are giving the world the hope that we can all live longer and better, improve our health and the health of the world.

To stay updated please remember to subscribe to our YouTube channel, and click the bell icon to get notifications for new episodes.

Episode Description:
In today's episode of Our Longevity Futures, Dr. Fahy discusses the results from his personal long-term health journey, his current work, and how he plans to improve human health and longevity.

In the future, will it be possible to extend our lives or increase our longevity by re-growing our thymus? Could epigenetic aging be reversed by re-growing the thymus? Greg Fahy is a cryobiologist who preserves organs and tissues, as well as an investigator of anti-aging treatment. His pilot study on reversing immune system aging was the first to provide conclusive evidence that aging could be reversed in humans.

Using that evidence Dr. Fahy’s company Intervene Immune, Inc. is expanding this pilot study to a Phase 2 clinical trial where he will be enrolling 85 participants between 40 and 80 years old. The clinical trial is called the Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X), and it aims to use a personalized combination of somatropin, metformin, and DHEA to regrow the participant’s thymus.

Links for Dr. Greg Fahy:
Intervene Immune: http://interveneimmune.com/?page_id=1200
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X): https://clinicaltrials.gov/ct2/show/N...
Book by Dr. The Future of Aging: Pathways to Human Life Extension: https://www.amazon.com/gp/product/904...

Links for Chris Curwen:
Twitter:   / curwenchris  
LinkedIn:   / christopher-curwen-67144b169  

Come join us at Gowing Life:
Our Website: https://www.gowinglife.com/​
Our Supplements Shop: https://shop.gowinglife.com/​
Our Twitter page:   / gowinglife​  
Our Facebook page:   / ​  
Our Instagram page:   / gowinglife